Sunshine Biopharma (SBFMW) Change in Receivables (2015 - 2026)
Sunshine Biopharma (SBFMW) reported Change in Receivables of $609601.0 for Q1 2026, up 242.87% on a YoY basis from $177792.0 in Q1 2025, and up 1576.28% quarter-over-quarter from -$41293.0 in Q4 2025.
Sunshine Biopharma (SBFMW) Change in Receivables (2015 - 2026) Analysis & Trends
Sunshine Biopharma has reported Change in Receivables for 10 years, with the latest figure at $609601.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 242.87% year-over-year to $609601.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 16.2% YoY), and the FY2025 full-year result was $116173.0, down 95.03% from the prior year.
- Change in Receivables for Q1 2026 stood at $609601.0, up from -$41293.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.8 million in Q2 2024, with the low at -$986986.0 in Q3 2024.
- Historically, Change in Receivables has averaged $261412.2 across 5 years, with a median of $127186.5 in 2023.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 3166200.0% — and 2024, when it plunged 1658.68%.
- Sunshine Biopharma's Change in Receivables stood at $532262.0 in 2022, then fell by 10.63% to $475659.0 in 2023, then surged by 113.81% to $1.0 million in 2024, then sank by 104.06% to -$41293.0 in 2025, then surged by 1576.28% to $609601.0 in 2026.
- The last three Change in Receivables figures came in at $609601.0 (Q1 2026), -$41293.0 (Q4 2025), and $649850.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 81.40 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 20.06 Mn |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 609,601.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 609,601.00 |
| Mar 31, 2026 | 609,601.00 |
| Dec 31, 2025 | -41,293.00 |
| Dec 31, 2025 | -41,293.00 |
| Sep 30, 2025 | 649,850.00 |
| Sep 30, 2025 | 649,850.00 |
| Jun 30, 2025 | -65,711.00 |
| Jun 30, 2025 | -65,711.00 |
| Mar 31, 2025 | -426,673.00 |
| Mar 31, 2025 | -426,673.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | -986,986.00 |
| Sep 30, 2024 | -986,986.00 |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 536,261.00 |
| Mar 31, 2024 | 536,261.00 |
| Dec 31, 2023 | 475,659.00 |
| Dec 31, 2023 | 475,659.00 |